Main Article Content
Medication Errors, Anti-Retroviral Agents, HIV Infections, Inpatients, United States
Background: Previous data reports inpatient antiretroviral (ARV) and opportunistic infection (OI) medication errors in as many as 86% of patients, with averages ranging from 1.16-2.7 errors/patient.
Objective: To determine the occurrence and type of inpatient ARV and OI medication errors at our institution.
Methods: A retrospective, observational, electronic medical chart review of patients with HIV/AIDS admitted between February 15, 2011- May 22, 2012 was conducted to assess the occurrence and type of ARV and OI medication errors. Secondary outcomes included assessing each medication with an error and evaluating its potential for a medication error, calculating a medication error rate per patient, evaluating whether a non-formulary (NF) medication impacted the error potential, determining whether a clinical pharmacist on service decreased the medication error rate, and assessing whether patients who experienced an error were more likely to have a longer length of stay (LOS). Analysis included descriptive statistics, averages, and Spearmen rank correlation.
Results: There were 344 patients included in this analysis, 132 (38%) experienced 190 medication errors (1.44 errors/patient). An omitted order was the most frequent ARV error and accounted for 30% (n=57) of total errors. There were 166 patients requiring OI medications, 37 patients experienced 39 medication errors. Omitting OI prophylaxis accounted for 31 errors. Only 45 of 190 (24%) errors were corrected prior to discharge. Being prescribed at least 1 NF medication was correlated with increased errors (n=193 patients “on NF medication”, p<0.025, r=0.12). Coverage of a service by a clinical pharmacist did not affect the number of errors. Patients experiencing an error had a longer LOS (p=0.02).
Conclusions: Errors relating to ARV and OI medications are frequent in HIV-infected inpatients. More errors occurred in patients receiving NF medications. Suggested interventions include formulary revision, education, and training. Dedicated HIV clinicians with adequate training and credentialing may improve the management of this specialized disease state.
2. P.I. Perspective: 25 years of information, inspiration and advocacy for people living with HIV/AIDS. Project Inform Web site. http://img.thebody.com/pinf/2010/pip50.pdf#page=7 (Accessed June 21, 2013).
3. Li EH, Foisy MM. Antiretroviral and medication errors in hospitalized HIV-positive patients. Ann Pharmacother. 2014;48(8):998-1010.
4. Purdy BD, Raymond AM, Lesar TS. Antiretroviral prescribing errors in hospitalized patients. Ann Pharmacother. 2000;34(7-8):833-838.
5. Snyder AM, Klinker K, Orrick JJ, Janelle J, Winterstein AG. An in-depth analysis of medication errors in hospitalized patients with HIV. Ann Pharmacother. 2011;45(4):459-468. doi: 10.1345/aph.1P599
6. Rastegar DA, Knight AM, Monolakis JS. Antiretroviral medication errors among hospitalized patients with HIV infection. Clin Infect Dis. 2006;43(7):933-938.
7. Mok S, Minson Q. Drug-related problems in hospitalized patients with HIV infection. Am J Health Syst Pharm. 2008;65(1):55-59.
8. Heelon M, Skiest D, Tereso G, Meade L, Weeks J, Pekow P, Rothberg MB. Effect of a clinical pharmacist’s interventions on duration of antiretroviral-related errors in hospitalized patients. Am J Health Syst Pharm. 2007;64(19):2064-2068.
9. Rao N, Patel V, Grigoriu A, Kaushik P, Brizuela M. Antiretroviral therapy prescribing in hospitalized HIV clinic patients. HIV Med. 2012;13(6):367-71. doi: 10.1111/j.1468-1293.2011.00977.x
10. Corrigan MA, Atkinson KM, Sha BE, Crank CW. Evaluation of pharmacy-implemented medication reconciliation directed at antiretroviral therapy in hospitalized HIV/AIDS patients. Ann Pharmacother. 2010;44(1):222-223. doi: 10.1345/aph.1M052
11. Micromedex Healthcare Series. DRUGDEX System. Greenwood Village, CO: Truven Health Analytics, 2013. http://www.thomsonhc.com/
12. Commers T, Swindells S, Sayles H, Gross AE, Devetten M, Sandkovsky U. Antiretroviral medication prescribing errors are common with hospitalization of HIV-infected patients. J Antimicrob Chemother. 2014;69(1):262-267. doi: 10.1093/jac/dkt323
13. Yehia BR, Mehta JM, Ciuffetelli D, Moore RD, Pham PA, Metlay JP, Gebo KA. Antiretroviral medication errors remain high but are quickly corrected among hospitalized HIV-infected adults. Clin Infect Dis. 2012;55(4):593-599. doi: 10.1093/cid/cis491
14. Pastakia SD, Corbett AH, Raasch RH, Napravnik S, Correll TA. Frequency of HIV-related medication errors and associated risk factors in hospitalized patients. Ann Pharmacother. 2008;42(4):491-497. doi: 10.1345/aph.1K547
15. Sanders J, Pallotta A, Bauer S, Sekeres J, Davis R, Taege A, Neuner E. Antimicrobial stewardship program to reduce antiretroviral medication errors in hospitalized patients with human immunodeficiency virus infection. Infect Control Hosp Epidemiol. 2014;35(3):272-277. doi: 10.1086/675287
16. Nachega JB, Parienti JJ, Uthman OA, Gross R, Dowdy DW, Sax PE, Gallant JE, Mugavero MJ, Mills EJ, Giordano TP. Lower pill burden and once-daily dosing antiretroviral treatment regimens for HIV infection: a meta-analysis of randomized controlled trials. Clin Infect Dis. 2014;58(9):1297-1307. doi: 10.1093/cid/ciu046
17. Kelly LS, Caulder CR, Bookstaver PB. Timely formulary management for preventing errors related to antiretroviral drugs. Am J Health Syst Pharm. 2013;70(12):1014-5. doi: 10.2146/ajhp130078
18. Arshad S, Rothberg M, Rastegar DA, Spooner LM, Skiest D. Survey of physician knowledge regarding antiretroviral medications in hospitalized HIV-infected patients. J Int AIDS Soc. 2009;12:1. doi: 10.1186/1758-2652-12-1
19. Holtzman CW, Gallagher JC. Antiretroviral Medication Errors Among Hospitalized HIV-Infected Adults. Clin Infect Dis. 2012;55(11):1585-1586. doi: 10.1093/cid/cis721
20. Clinician Consultation Center. HIV/AIDS Management Web site. Available at http://nccc.ucsf.edu/clinician-consultation/hiv-aids-management/ (Accessed November 21, 2014).
21. Max BE, Itokazu G, Danziger LH, Weinstein RA. Assessing unit dose system discrepancies. Am J Health Syst Pharm. 2002;59(9):856-858.